Finance

Lists
600276:SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
46,63 CN¥
+0,06%
(+0,030) 1D
16 қаз., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600276...
Open
46,25 CN¥
High
47,58 CN¥
Low
45,51 CN¥
Mkt. cap
297,45 млрд
Avg. vol.
59,82 млн
Volume
68,74 млн
Dividend
0,43%
Quarterly dividend
0,05 CN¥
Ex-dividend date
2026 ж. 27 мам.
P/E ratio
40,02
52-wk high
68,50 CN¥
52-wk low
41,89 CN¥
EPS
1,17 CN¥
Shares outstanding
3,68 млрд
No. of employees
21 мың
Open
46,25 CN¥
High
47,58 CN¥
Low
45,51 CN¥
Mkt. cap
297,45 млрд
Avg. vol.
59,82 млн
Volume
68,74 млн
Dividend
0,43%
Quarterly dividend
0,05 CN¥
Ex-dividend date
2026 ж. 27 мам.
P/E ratio
40,02
52-wk high
68,50 CN¥
52-wk low
41,89 CN¥
EPS
1,17 CN¥
Shares outstanding
3,68 млрд
No. of employees
21 мың
News stories
From web sources and news partners
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees20,7 мың
Founded1970
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
7,43 млрд
8,44 млрд
8,14 млрд
7,32 млрд
Cost of goods sold
1,07 млрд
1,25 млрд
1,09 млрд
1,02 млрд
Cost of revenue
1,07 млрд
1,25 млрд
1,09 млрд
1,02 млрд
Research and development expenses
1,72 млрд
2,02 млрд
1,65 млрд
1,84 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,23 млрд
3,01 млрд
2,81 млрд
2,78 млрд
Operating expense
4,76 млрд
5,35 млрд
4,48 млрд
4,61 млрд
Total operating expenses
5,83 млрд
6,60 млрд
5,57 млрд
5,63 млрд
Operating income
1,60 млрд
1,84 млрд
2,57 млрд
1,68 млрд
Other non operating income
-154,21 млн
145,74 млн
-345,12 млн
243,91 млн
EBT including unusual items
1,36 млрд
2,30 млрд
2,56 млрд
2,40 млрд
EBT excluding unusual items
1,68 млрд
1,91 млрд
2,55 млрд
1,60 млрд
Income tax expense
55,51 млн
338,85 млн
275,87 млн
211,27 млн
Effective tax rate
4,08%
14,76%
10,79%
8,82%
Other operating expenses
-217,30 млн
326,84 млн
4,76 млн
-5,09 млн
Net income
1,30 млрд
1,96 млрд
2,28 млрд
2,18 млрд
Net profit margin
17,52%
23,22%
28,04%
29,84%
Earnings per share
0,20
-
-
-
Interest and investment income
242,14 млн
288,66 млн
322,96 млн
448,28 м.
Interest expense
-689,68 м.
-2,00 млн
-448,28 м.
-322,96 млн
Net interest expenses
241,45 млн
286,66 млн
322,52 млн
-322,52 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,78 млрд
2,04 млрд
2,77 млрд
1,93 млрд
Gain or loss from assets sale
2,31 млн
-4,05 млн
-
-40,62 млн
AI content may include mistakes. Learn more
Google қолданбалары